Henan Lingrui Pharmaceutical Co., Ltd. (SHA:600285)
19.70
+0.03 (0.15%)
Aug 14, 2026, 3:00 PM CST
SHA:600285 Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 743.7 | 382.84 | 1,228 | 1,499 | 1,179 | 801.24 |
Short-Term Investments | - | 547.59 | 283.01 | 95.63 | 125.34 | 140.77 |
Trading Asset Securities | 130.31 | 160.35 | - | 0.21 | 150.42 | 280.19 |
Cash & Short-Term Investments | 874.01 | 1,091 | 1,511 | 1,595 | 1,455 | 1,222 |
Cash Growth | -22.79% | -27.83% | -5.23% | 9.60% | 19.05% | 47.32% |
Accounts Receivable | 877.28 | 713.34 | 488.95 | 498.99 | 511.97 | 431.18 |
Other Receivables | 14.27 | 7.1 | 6.29 | 19.35 | 21.37 | 9.58 |
Receivables | 891.55 | 720.44 | 495.23 | 518.34 | 533.34 | 440.77 |
Inventory | 359.1 | 436.64 | 434.97 | 467.35 | 486.41 | 428.39 |
Other Current Assets | 713.26 | 32.02 | 16.45 | 18.51 | 33.58 | 39.87 |
Total Current Assets | 2,838 | 2,280 | 2,458 | 2,599 | 2,508 | 2,131 |
Property, Plant & Equipment | 707.15 | 682.62 | 631.2 | 647.81 | 706.76 | 732.92 |
Long-Term Investments | 239.47 | 1,570 | 1,437 | 1,069 | 676.63 | 364.7 |
Goodwill | 482.02 | 482.02 | - | - | - | - |
Other Intangible Assets | 343.38 | 330.14 | 203.75 | 202.5 | 203.65 | 236.95 |
Long-Term Deferred Tax Assets | 230.41 | 198.35 | 199.59 | 186.92 | 159.2 | 116.49 |
Long-Term Deferred Charges | 20.11 | 18.54 | 12.34 | 36.73 | 51.54 | 65.53 |
Other Long-Term Assets | 895.15 | 73.48 | 74.45 | 29.98 | 38.45 | 145.25 |
Total Assets | 5,756 | 5,636 | 5,017 | 4,772 | 4,345 | 3,793 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 92.1 | 97.27 | 85.13 | 57.38 | 68.02 | 78.01 |
Accrued Expenses | 144.01 | 1,121 | 1,176 | 1,110 | 917.79 | 600.38 |
Short-Term Debt | 361.05 | 409.52 | 90.47 | 199.94 | 151.15 | 272.34 |
Current Portion of Long-Term Debt | 1.94 | - | - | - | - | - |
Current Portion of Leases | - | 2.59 | 1.78 | 1.08 | 1.22 | 1.65 |
Current Income Taxes Payable | 147.75 | 49.81 | 56.28 | 70.72 | 55.54 | 46.9 |
Current Unearned Revenue | 66.8 | 83.64 | 114.28 | 114.48 | 153.75 | 79.09 |
Other Current Liabilities | 1,594 | 352.12 | 350.24 | 346.95 | 364.47 | 359.28 |
Total Current Liabilities | 2,408 | 2,116 | 1,874 | 1,900 | 1,712 | 1,438 |
Long-Term Leases | 3.55 | 4.27 | 6.55 | 6.96 | 6.2 | 7.9 |
Long-Term Unearned Revenue | 35.38 | 31 | 33.4 | 39.78 | 38.55 | 42.78 |
Long-Term Deferred Tax Liabilities | 39 | 48.74 | 22.27 | 26.32 | 29.56 | 18.18 |
Total Liabilities | 2,486 | 2,200 | 1,937 | 1,973 | 1,786 | 1,507 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 567.12 | 567.12 | 567.12 | 567.14 | 567.46 | 567.76 |
Additional Paid-In Capital | 371.04 | 367.2 | 340.61 | 326.23 | 309.82 | 272.02 |
Retained Earnings | 2,310 | 2,438 | 2,181 | 1,894 | 1,664 | 1,481 |
Treasury Stock | -5.6 | -12.58 | -13.7 | -47.4 | -67.62 | -98.19 |
Comprehensive Income & Other | -10.62 | 40.41 | -2.02 | 51 | 76.74 | 56.08 |
Total Common Equity | 3,232 | 3,401 | 3,073 | 2,791 | 2,551 | 2,279 |
Minority Interest | 38.12 | 35.33 | 7.77 | 7.66 | 7.55 | 7.59 |
Shareholders' Equity | 3,270 | 3,436 | 3,080 | 2,799 | 2,558 | 2,287 |
Total Liabilities & Equity | 5,756 | 5,636 | 5,017 | 4,772 | 4,345 | 3,793 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 366.54 | 416.38 | 98.8 | 207.99 | 158.57 | 281.89 |
Net Cash (Debt) | 507.47 | 674.41 | 1,413 | 1,387 | 1,296 | 940.31 |
Net Cash Growth | -16.90% | -52.26% | 1.86% | 6.96% | 37.88% | 41.69% |
Net Cash Per Share | 0.89 | 1.19 | 2.50 | 2.45 | 2.28 | 1.66 |
Filing Date Shares Outstanding | 566.65 | 566.13 | 564.42 | 563.94 | 569.61 | 564.55 |
Total Common Shares Outstanding | 566.65 | 566.13 | 564.42 | 563.94 | 569.61 | 564.55 |
Working Capital | 429.99 | 164.31 | 583.7 | 698.77 | 796.44 | 693.59 |
Book Value Per Share | 5.70 | 6.01 | 5.44 | 4.95 | 4.48 | 4.04 |
Tangible Book Value | 2,406 | 2,588 | 2,869 | 2,589 | 2,347 | 2,042 |
Tangible Book Value Per Share | 4.25 | 4.57 | 5.08 | 4.59 | 4.12 | 3.62 |
Buildings | - | 659.16 | 588.03 | 593.96 | 595.01 | 582.83 |
Machinery | - | 672.16 | 591.9 | 581.63 | 581.92 | 534.7 |
Construction In Progress | - | 16.01 | 34.2 | 2.88 | 1.92 | 24.78 |